MRK - Merck & Co., Inc.

NYSE - NYSE 延遲價格。貨幣為 USD。

Merck & Co., Inc.

126 East Lincoln Avenue
Rahway, NJ 07065
United States
908 740 4000

行業Drug Manufacturers—General


Mr. Robert M. Davis J.D.Chairman, Pres & CEO6.08M6.77M1967
Ms. Caroline LitchfieldExec. VP & CFO2.8M1969
Ms. Jennifer L. ZacharyExec. VP & Gen. Counsel2.73M3.46M1978
Dr. Dean Y. Li M.D., Ph.D.Exec. VP & Pres of Merck Research Laboratories3.44M1962
Mr. Chirfi GuindoSr. VP & Chief Marketing Officer for Merck Human Health1.54M1966
Mr. David Michael WilliamsExec. VP and Chief Information & Digital Officer1969
Mr. Peter DannenbaumVP of Investor Relations
Lisa LeCointe-CephasSr. VP and Chief Ethics & Compliance Officer1982
Ms. Cristal N. DowningExec. VP and Chief Communications & Public Affairs Officer1970
Mr. Steven C. MizellExec. VP & Chief HR Officer1960
截止 2022年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。


Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics LP; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.


截至 2023年6月1日 止,Merck & Co., Inc. 的 ISS 管治質素評分為 4。 Pillar 分數正在審核中:5;董事會:6;股東權利:3;現金賠償:4。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。